TY - JOUR
T1 - Tuberculosis in New York city
T2 - Recent lessons and a look ahead
AU - Paolo, William F.
AU - Nosanchuk, Joshua D.
N1 - Funding Information:
JDN was supported by NIH AI52733 and an Albert Einstein College of Medicine Center for AIDS Research grant. We thank Penny Youngs, Samuel Feuer, and JoAnn Tufariello for their critical reading of the manuscript.
PY - 2004/5/1
Y1 - 2004/5/1
N2 - In the late 1980s and early 1990s, after decades of decline, the incidence of tuberculosis began to rise in New York city, reaching a peak of 3811 cases by 1992. The epidemic took root in a setting of inadequate treatment regimens, homelessness, a diminished public-health system, and the onset of the HIV/AIDS epidemic. In addition, a subepidemic of drug-resistant tuberculosis occurred throughout New York city, most notably in a series of well documented nosocomial outbreaks. By 1994, using broadened initial treatment regimens, directly observed therapy, and improved US Centers for Disease Control and Prevention guidelines for hospital control and disease prevention, New York city began to effectively halt the progression of the epidemic. By 2002, tuberculosis rates in New York city reached an historic low of 1084. However, given the presence of a large reservoir of latently infected individuals in the city and an ongoing tuberculosis pandemic, New York city continues to face significant challenges from this persistent pathogen.
AB - In the late 1980s and early 1990s, after decades of decline, the incidence of tuberculosis began to rise in New York city, reaching a peak of 3811 cases by 1992. The epidemic took root in a setting of inadequate treatment regimens, homelessness, a diminished public-health system, and the onset of the HIV/AIDS epidemic. In addition, a subepidemic of drug-resistant tuberculosis occurred throughout New York city, most notably in a series of well documented nosocomial outbreaks. By 1994, using broadened initial treatment regimens, directly observed therapy, and improved US Centers for Disease Control and Prevention guidelines for hospital control and disease prevention, New York city began to effectively halt the progression of the epidemic. By 2002, tuberculosis rates in New York city reached an historic low of 1084. However, given the presence of a large reservoir of latently infected individuals in the city and an ongoing tuberculosis pandemic, New York city continues to face significant challenges from this persistent pathogen.
UR - http://www.scopus.com/inward/record.url?scp=2342418470&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342418470&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(04)01004-7
DO - 10.1016/S1473-3099(04)01004-7
M3 - Review article
C2 - 15120345
AN - SCOPUS:2342418470
SN - 1473-3099
VL - 4
SP - 287
EP - 293
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 5
ER -